Interpretive Handbook
‹ Back to index | Back to list | More information
Test 9265:
Amino Acids, Quantitative, Plasma
Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Amino acids are the basic structural units that comprise proteins, and are found throughout the body. Many inborn errors of amino acid metabolism, including phenylketonuria and tyrosinemia, which affect amino acid transport and/or metabolism have been identified. Amino acid disorders can manifest at any time in a person's life, but most become evident in infancy or early childhood. These disorders result in the accumulation or the deficiency of 1 or more amino acids in biological fluids which leads to the clinical signs and symptoms of the particular amino acid disorder.
The clinical presentation is dependent upon the specific amino acid disorder. In general, affected patients may experience failure to thrive, neurologic symptoms, digestive problems, dermatologic findings, and physical and cognitive delays. If not diagnosed and treated promptly, amino acid disorders can result in mental retardation and death.
Treatment for amino acid disorders involves very specific dietary modifications. Nonessential amino acids are synthesized by the body, while essential amino acids are not and must be obtained through an individual’s diet. Therapeutic diets are coordinated and closely monitored by a dietician and/or physician. They are structured to provide the necessary balance of amino acids with particular attention to essential amino acids and those which accumulate in a particular disorder. Patients must pay close attention to the protein content in their diet and generally need to supplement with medical formulas and foods. Dietary compliance is monitored by periodic analysis of amino acids.
In addition, amino acid analysis may have clinical importance in the evaluation of several acquired conditions including endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, renal failure, and burns.
Useful For
Suggests clinical disorders or settings where the test may be helpful
Evaluating patients with possible inborn errors of metabolism
May aid in evaluation of endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, renal failure, and burns
Interpretation
Provides information to assist in interpretation of the test results
When abnormal results are detected, a detailed interpretation is given, including an overview of the results and of their significance, a correlation to available clinical information, elements of differential diagnosis, recommendations for additional biochemical testing, and in vitro confirmatory studies (enzyme assay, molecular analysis), name and phone number of key contacts who may provide these studies at Mayo or elsewhere, and a phone number to reach one of the laboratory directors in case the referring physician has additional questions.
Cautions
Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
Reference values are for fasting patients.
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
| Plasma Amino Acid Reference Values (nmol/mL) | Age Groups | ||
| <24 Months (n=191) | 2-17 Years (n=441) | > or =18 Years (n=148) | |
| Phosphoserine (PSer) | <109 | <95 | <18 |
| Phosphoethanolamine (PEtN) | <6 | <5 | <12 |
| Taurine (Tau) | 37-177 | 38-153 | 42-156 |
| Asparagine (Asn) | 25-91 | 29-87 | 37-92 |
| Serine (Ser) | 69-271 | 71-208 | 63-187 |
| Hydroxyproline (Hyp) | 8-61 | 7-35 | 4-29 |
| Glycine (Gly) | 111-426 | 149-417 | 126-490 |
| Glutamine (Gln) | 316-1020 | 329-976 | 371-957 |
| Aspartic Acid (Asp) | 2-20 | <11 | <7 |
| Ethanolamine (EtN) | <70 | <64 | <67 |
| Histidine (His) | 10-116 | 12-132 | 39-123 |
| Threonine (Thr) | 47-237 | 58-195 | 85-231 |
| Citrulline (Cit) | 9-38 | 11-45 | 17-46 |
| Sarcosine (Sar) | <5 | <5 | <5 |
| b-Alanine (bAla) | <28 | <27 | <29 |
| Alanine (Ala) | 139-474 | 144-557 | 200-579 |
| Glutamic Acid (Glu) | 31-202 | 22-131 | 13-113 |
| 1-Methylhistidine (1MHis) | <11 | <20 | <28 |
| 3-Methylhistidine (3MHis) | <1 | <1 | 2-9 |
| Argininosuccinic Acid (Asa) | <2 | <2 | <2 |
| Carnosine (Car) | <13 | <1 | <1 |
| Anserine (Ans) | <1 | <1 | <1 |
| Homocitruline (Hcit) | <5 | <2 | <2 |
| Arginine (Arg) | 29-134 | 31-132 | 32-120 |
| a-Aminoadipic Acid (Aad) | <4 | <3 | <3 |
| g-Amino-n-butyric Acid (GABA) | <4 | <3 | <2 |
| b-Aminoisobutyric Acid (bAib) | <9 | <5 | <5 |
| a-Amino-n-butyric Acid (Abu) | 7-28 | 7-31 | 9-37 |
| Hydroxylysine (Hyl) | <4 | <3 | <2 |
| Proline (Pro) | 85-303 | 80-357 | 97-368 |
| Ornithine (Orn) | 20-130 | 22-97 | 38-130 |
| Cystathionine (Cth) | <2 | <2 | <5 |
| Cystine (Cys) | 2-32 | 2-36 | 3-95 |
| Lysine (Lys) | 49-204 | 59-240 | 103-255 |
| Methionine (Met) | 11-35 | 11-37 | 4-44 |
| Valine (Val) | 83-300 | 106-320 | 136-309 |
| Tyrosine (Tyr) | 26-115 | 31-106 | 31-90 |
| Homocystine (Hcy) | NA | NA | <5 |
| Isoleucine (IIe) | 31-105 | 30-111 | 36-107 |
| Leucine (Leu) | 48-175 | 51-196 | 68-183 |
| Phenylalanine (Phe) | 28-80 | 30-95 | 35-80 |
| Tryptophan (Trp) | 17-75 | 23-80 | 29-77 |
| Alloisoleucine (Allolle) | <2 | <3 | <5 |
Clinical References
Provides recommendations for further in-depth reading of a clinical nature
Amino acids. In The Metabolic and Molecular Bases of Inherited Disease. Eighth edition. Edited by CR Scriver, AL Beaudet, WS Sly, et al. New York, McGraw-Hill, Inc. 2001, pp 1667-2105


